text: There are multiple approaches to measuring a persons exposure to pesticides, each of which provides an estimate of an individuals internal dose. Two broad approaches include measuring biomarkers and markers of biological effect. The former involves taking direct measurement of the parent compound or its metabolites in various types of media: urine, blood, serum. Biomarkers may include a direct measurement of the compound in the body before its been biotransformed during metabolism. Other suitable biomarkers may include the metabolites of the parent compound after theyve been biotransformed during metabolism. Toxicokinetic data can provide more detailed information on how quickly the compound is metabolized and eliminated from the body, and provide insights into the timing of exposure.
  Markers of biological effect provide an estimation of exposure based on cellular activities related to the mechanism of action. For example, many studies investigating exposure to pesticides often involve the quantification of the acetylcholinesterase enzyme at the neural synapse to determine the magnitude of the inhibitory effect of organophosphate and carbamate pesticides.
  Another method of quantifying exposure involves measuring, at the molecular level, the amount of pesticide interacting with the site of action. These methods are more commonly used for occupational exposures where the mechanism of action is better understood, as described by WHO guidelines published in "Biological Monitoring of Chemical Exposure in the Workplace". Better understanding of how pesticides elicit their toxic effects is needed before this method of exposure assessment can be applied to occupational exposure of agricultural workers.
  Alternative methods to assess exposure include questionnaires to discern from participants whether they are experiencing symptoms associated with pesticide poisoning. Self-reported symptoms may include headaches, dizziness, nausea, joint pain, or respiratory symptoms.